(Total Views: 565)
Posted On: 01/16/2020 10:54:10 AM
Post# of 153815
So Nader wisely stayed in San Francisco at the conference….
Was he attending other conferences and learning about new drugs & products ?? I don't think so.
Was he making himself available for further questioning ??? Maybe
Was he trying to make himself available for conversations in possible partnerships/commercialization/mergers ??? You bet !!
I will be listening very carefully to the next interview for clues regarding NEW possible deals.
Remember: we have still the whole word ex-USA for HIV and this is approaching (LBA+approval)…. We should hear about more deals especially the China, Japan and EU deals that should be very substancial.
Now, in regards to Oncology, maybe some companies would ve wise enough so as to start "testing the water" in case data continues to be so good. Next weeks will be critical in this respect (apologies for repeating the obvious but I am exited about the possibilities).
Exciting times lie ahead ...
Was he attending other conferences and learning about new drugs & products ?? I don't think so.
Was he making himself available for further questioning ??? Maybe
Was he trying to make himself available for conversations in possible partnerships/commercialization/mergers ??? You bet !!
I will be listening very carefully to the next interview for clues regarding NEW possible deals.
Remember: we have still the whole word ex-USA for HIV and this is approaching (LBA+approval)…. We should hear about more deals especially the China, Japan and EU deals that should be very substancial.
Now, in regards to Oncology, maybe some companies would ve wise enough so as to start "testing the water" in case data continues to be so good. Next weeks will be critical in this respect (apologies for repeating the obvious but I am exited about the possibilities).
Exciting times lie ahead ...
(8)
(0)
